We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lilly Seeks To Stay Whistleblower Suit Over Zyprexa

Law360 (October 3, 2007, 12:00 AM EDT) -- Eli Lilly & Co. is seeking to stay a whistleblower suit over charges it marketed its blockbuster anti-psychotic drug Zyprexa for off-label uses, arguing the case should be joined with a multidistrict product liability litigation pending in a New York district court.

In court documents filed Wednesday in the U.S. District Court for the Northern District of California, Lilly said the action raises many issues that are already the subject of ongoing multidistrict proceedings in the U.S. District Court for the Eastern District of New York....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.